Showing posts with label placebos. Show all posts
Showing posts with label placebos. Show all posts

Monday, March 16, 2009

Placebo prescriptions leave patients in the dark

Medical Tribune January 2009 P4
David Brill

US physicians regularly prescribe placebo treatments but are rarely open with their patients about doing so, a recent study suggests.

Sixty-two percent of physicians who completed a postal survey said that prescribing placebos was ethically permissible, and almost half reported doing so at least 2 or 3 times per month.

However just 5 percent of those who gave placebos said that they explicitly described them as such to their patients. The majority – around two thirds – usually described the treatment as a medicine which is not typically used for that particular condition but which might be of benefit.

“Our study seems to suggest that doctors may be using placebo treatments and they may be cutting corners in terms of how they describe them to patients,” said lead researcher Dr. Jon Tilburt, currently an assistant professor of medicine at the Mayo Clinic, US.

“I don’t think that these data show that doctors are actively deceiving their patients all the time,” he added, noting that the use of truly ‘inactive’ placebos was reported by less than 3 percent of the respondents.

“Physicians rarely use treatments such as sugar pills or saline in which there is no evidence that it could even possibly have a physiological benefit. Those treatments, I think, would be more closely aligned with overt deception,” he said.

Over-the-counter painkillers and vitamins were the most common choices of placebo in the study, with 41 and 38 percent of physicians, respectively, having recommended these treatments in the past year. Sedatives and antibiotics had each been recommended by 13 percent of physicians during that time.

Although the study did not address the complex issues that underlie physicians’ motivations for prescribing placebos, Tilburt believes that in general they have their patients’ best interests at heart when doing so.

“Physicians have a deep impulse to help but when you put them in a circumstance where they cannot fully realize that impulse they still want to do something, even if it comes at some expense to informed consent. And because we don’t have a healthcare system that reimburses for reassurance, good conversations and a quality relationship, we sometimes substitute pills for those more existential aspects of our caring,” he said.

Dr. Thiru Thirumoorthy, a former director of the Singapore Medical Association’s Centre for Medical Ethics and Professionalism, said that placebos have historically been an acceptable part of the healing process in all cultures – particularly among eastern traditions. He noted, however, that doctors need to exercise their judgment before prescribing placebos and must be able to show that they have acted in the patient’s best interests when called to account.

“Placebos must not cause harm, should not take the place of other effective medications, and should not be used unless all other proven treatments have been exhausted or are contraindicated,” he said.

“Placebos should not be used to create a dependency situation. Patient empowerment must be promoted in diseases that do not have effective treatments.”

The survey by Tilburt et al. was completed by 679 practicing rheumatologists and general internists. The researchers defined a placebo as “a treatment whose benefits (in the opinion of the clinician) derive from positive patient expectations and not from the physiological mechanism of the treatment itself.” [BMJ 2008 Oct 23;337:a1938. doi: 10.1136/bmj.a1938]

Future research is directed at understanding whether the power of the placebo effect can be harnessed without keeping patients in the dark, Tilburt said.

“There is some suggestion that even when we tell patients that they’re going to get a placebo there is still some placebo benefit. There’s probably some detriment in the degree of efficacy when you eliminate deception but it’s not totally eliminated, which is fascinating.”

Wednesday, February 18, 2009

A sympathetic ear: The best medicine for irritable bowels

Medical Tribune November 2008 SFIX
David Brill

Listening to your patients could be an effective treatment for irritable bowel syndrome (IBS), a recent study has suggested.

Researchers from the US and UK found that 62 percent of patients reported adequate symptom relief when their doctor spent more time with them and asked questions in a warm and friendly manner, in addition to providing placebo acupuncture.

Forty four percent of patients showed the same improvement when acupuncture was given without the extra attention, and just 28 percent when no placebo therapy was given at all.

Professor Ted Kaptchuk, who led the study, said that it was one of the most important demonstrations of the placebo effect in the literature and the first to look at long-term outcomes in the clinical setting.

“The important implication is that the power of the placebo effect, and specifically the patient-doctor component of the placebo effect, was huge. The magnitude of that effect is comparable to any drug that’s ever been tested for irritable bowel,” said Kaptchuk, who is based at Harvard Medical School, US.

He added that the same principles could apply to situations such as chronic pain and depression, which also have a strong “subjective component” whereby the context of the healthcare situation can influence a patient’s interpretation of their condition.

“We’re not treating something that is defined biologically, say a tumor or a blood assay or something you find on an X-ray. We’re treating a complaint that’s very real, and the interactions of that complaint with the person’s sense of well-being and health is probably where the placebo effect is very important,” he said.

The study involved 262 patients who were randomized to receive one of the two placebo interventions or simply to remain on a waiting list. The effects were recorded at 3 weeks and remained similar after 6. [BMJ 336(7651):999-1003]

Dr. Gwee Kok Ann, a Singapore-based IBS specialist and president of the IBS Support Group, was not surprised by the study’s findings.

“I’ve always felt that IBS patients respond very well to treatment if you just make the effort to talk with them and explain things to them,” he said.

“A lot of times it’s just helping the patient first of all to understand what’s going on because I think that’s the main worry in a lot of them. They worry is it cancer, is it colitis, and that in itself reinforces the symptoms because anxiety drives the symptoms too,” said Gwee, an adjunct associate professor at the National University of Singapore and a consultant gastroenterologist at Gleneagles Hospital.

Addressing the diagnosis of IBS in a tactful way can also improve outcomes, he said, noting that doctors should take time to explain the condition thoroughly and convincingly so that the patient is comfortable with the diagnosis.

Patients view pain as a warning that something is wrong, he explained, so if their doctor can’t find an explanation for it then adrenaline and anxiety can rise, prompting the patient to demand more and more tests in the expectation that something has been missed. This situation can be avoided by introducing the diagnosis of IBS early rather than leaving it as a last resort for when everything else has been ruled out, he said.